The allelic groups DRB1*11 and DRB1*15, which were associated with COVID-19 severity in the non-severe vs. severe comparison, showed sufficient statistical power for the sample size, with 83% and 91% power, respectively. This evidence concerns the gene HLA-DRB1 and COVID-19.